Biological indicators and genetic information in Danish Twin and oldest-old surveys

Biosocial Surveys

Volumn , Issue , 2008, Pages 15-41

  Christensen, Kaare ^a,b   Bathum, Lise ^c   Christiansen, Lene ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b DUKE UNIVERSITY   (United States)

^c Slagelse Hospital in Region Zealand   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85009318026     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.17226/11939     Document Type: Chapter

References (80)

1. Andersen-Ranberg, K., Schroll, M., and Jeune, B. (2001). Healthy centenarians do not exist, but autonomous do: A population-based study of morbidity among Danish centenarians. Journal of the American Geriatrics Society, 49 , 900-908.
2. Barbieri, M., Ferrucci, L., Ragno, E., Corsi, A., Bandinelli, S., Bonafe, M., Olivieri, F., Giovagnetti, S., Franceschi, C., Guralnik, J.M., and Paolisso, G. (2003). Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. American Journal of Physiology, Endocrinology, and Metabolism, 284 , E481-E487.
3. Bathum, L., Christiansen, L., Tan, Q., Vaupel, J., Jeune, B., and Christensen, K. (2005). No evidence for an association between extreme longevity and microsomal transfer protein polymorphisms in a longitudinal study of 1651 nonagenarians. European Journal of Human Genetics, 13 , 1154-1158.
4. Beekman, M., Blauw, G.J., Houwing-Duistermaat J.J., Brandt B.W., Westendorp, R.G, and Slagboom, P.E. (2006). Chromosome 4q25, microsomal transfer protein gene, and human longevity: novel data and a meta-analysis of association studies. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 61 (4), 355-362.
5. Bischoff, C., Petersen, H.C., Graakjaer, J., Andersen-Ranberg, K., Vaupel, J.W., Bohr, V.A., Kølvraa, S., and Christensen, K. (2006). No association between telomere length and survival among the elderly and oldest-old. Epidemiology, 17 (2), 90-194.
6. Bladbjerg, E.M., Andersen-Ranberg, K., de Maat, M.P., Kristensen, S.R., Jeune, B., Gram, J., and Jespersen, J. (1999). Longevity is independent of common variations in genes associated with cardiovascular risk. Journal of Thrombosis and Haemostasis, 82 , 1100-1105.
7. Blanche, H., Cabanne, L., Sahbatou, M., and Thomas, G. (2001). A study of French centenarians: Are ACE and APOE associated with longevity? Comptes Fendus de l'Académie des Sciences. Série III, 324 , 129-135.
8. Bonaccorso, S., Lin, A., Song, C., Verkerk, R., Kenis, G., Bosmans, E., Scharpe, S., Vandewoude, M., Dossche, A., and Maes, M. (1998). Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer's disease (DAT): Lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT. Aging (Milano), 10, 316-323.
9. Borkan, G.A., Bachman, S.S., and Norris, A.H. (1982). Comparison of visually estimated age with physiologically predicted age as indicators of rates of aging. Social Science and Medicine, 16 , 197-204.
10. Bruunsgaard, H., Pedersen, M., and Pedersen, B.K. (2001). Aging and proinflammatory cytokines. Current Opinion in Hematology, 8, 131-136.
11. Cawthon, R.M., Smith, K.R., O'Brien, E., Sivatchenko, A., and Kerber, R.A. (2003). Association between telomere length in blood and mortality in people aged 60 years or older. The Lancet, 361 , 393-395.
12. Cherif, H., Tarry, J.L., Ozanne, S.E., and Hales, C.N. (2003). Ageing and telomeres: A study into organ- and gender-specific telomere shortening. Nucleic Acids Research, 31 , 1576- 1583.
13. Christensen, K. (2000). Biological material in household surveys: The interface between epidemiology and genetics. In National Research Council, Cells and surveys: Should biological measures be included in social science research? (pp. 42-63). Committee on Population, C.E. Finch, J.W. Vaupel, and K. Kinsella (Eds.). Commission on Behavioral and Social Sciences and Education. Washington, DC: National Academy Press.
14. Christensen, K., Iachina, M., Rexbye, H., Tomassini, C., Frederiksen, H., McGue, M., and Vaupel, J.W. (2004). Looking old for your age: Genetics and mortality. Epidemiology, 15 , 251-252.
15. Christensen, K., Johnson, T.E., and Vaupel, J.W. (2006). The quest for genetic determinants of human longevity: Challenges and insights. Nature Reviews Genetics, 7(6), 436-448.
16. Christensen, K., Kristiansen, M., Hagen-Larsen, H., Skytthe, A., Bathum, L., Jeune, B., Andersen-Ranberg, K., Vaupel, J.W., and Ørstavik, K.H. (2000). X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood, 95 , 2449-2451.
17. Christiansen, L., Bathum, L., Andersen-Ranberg, K., Jeune, B., and Christensen, K. (2004). Modest implication of interleukin-6 promoter polymorphisms in longevity. Mechanisms of Ageing and Development, 125 (5), 391-395.
18. Cohen, H.J., Pieper, C.F., Harris, T., Rao, K.M., and Currie, M.S. (1997). The association of plasma IL-6 levels with functional disability in community-dwelling elderly. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 52 , M201-M208.
19. Corder, E.H., Lannfelt, L., Viitanen, M., Corder, L.S., Manton, K.G., Winblad, B., and Basun, H. (1996). Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Archives of Neurology, 53 , 418-422.
20. Costa, L.G., Vitalone A., Cole T.B., and Furlong C.E. (2005). Modulation of paraoxonase (PON1) activity. Biochemical Pharmacology, 69 (4), 541-550.
21. de Craen, A.J., et al. (2005). Genetic influence of innate immunity: An extended twin study. Genes and Immunity, 6, 167-170.
22. de Maat, M.P., Bladbjerg, E.M., Hjelmborg, J.B., Bathum, L., Jespersen, J., Christensen, K., et al. (2004). Genetic influence on inflammation variables in the elderly. Arteriosclerosis, Thrombosis, and Vascular Biology, 24 , 2168-2173.
23. Ershler, W.B, and Keller, E.T. (2000). Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annual Review of Medicine, 51 , 245-270.
24. Ewbank, D.C. (2004). The APOE gene and differences in life expectancy in Europe. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 50, B16-B20.
25. Ferrucci, L., Harris, T.B., Guralnik, J.M., Tracy, R.P., Corti, M.C., Cohen, H.J., Penninx, B., Pahor, M., Wallace, R., and Havlik, R.J. (1999). Serum IL-6 level and the development of disability in older persons. Journal of the American Geriatrics Society, 47 , 639-646.
26. Finch, C.E., and Crimmins, E.M. (2004). Inflammatory exposure and historical changes in human life-spans. Science, 305, 1736-1739.
27. Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S., and Woo, P. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102, 1369-1376.
28. Franceschi, C., Bonafe, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., and de Benedictis, G. (2000). Inflamm-aging. An evolutionary perspective on immunosenescence.
29. Frederiksen, H., and Christensen, K. (2003). The influence of genetic factors on physical functioning and exercise in second half of life. Scandinavian Journal of Medicine and Science in Sports, 13 (1), 9-18.
30. Frederiksen, H., Gaist, D., Bathum, L., Andersen, K., McGue, M., Vaupel, J.W., and Christensen, K. (2003). Angiotensin I-converting enzyme (ACE) gene polymorphism in relation to physical performance, cognition, and survival: A follow-up study of elderly Danish twins. Annals of Epidemiology, 13 , 57-65.
31. Gayagay, G., Yu, B., Hambly, B., Boston, T., Hahn, A., Celermajer, D.S., and Trent, R.J. (1998). Elite endurance athletes and the ACE I allele: The role of genes in athletic performance. American Journal of Human Genetics, 103, 48-50.
32. Geesaman, B.J., Benson, E., Brewster, S.J., Kunkel, L.M., Blanche, H., Thomas, G., Perls, T.T., Daly, M.J., and Puca, A.A. (2003). Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan. Proceedings of the National Academy of Sciences, USA, 100, 14115-14120.
33. Georges, J.L., Loukaci, V., Poirier, O., Evans, A., Luc, G., Arveiler, D., Ruidavets, J.B., Cambien, F., and Tiret, L. (2001). Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: The ECTIM study. (Etude Cas-Temoin de l'Infarctus du Myocarde). International Journal of Molecular Medicine, 79 , 300-305.
34. Gerdes, L.U., Jeune, B., Ranberg, K.A., Nybo, H., and Vaupel, J.W. (2000). Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: Apolipoprotein E gene is a frailty gene, not a longevity gene. Genetic Epidemiology, 19 , 202-210.
35. Goldman, N., Turra, C.M., Glei, D.A., Seplaki, C.L., Lin, Y., Weinstein, M. (2006). Predicting mortality from clinical and nonclinical biomarkers. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 61 A(10), 1070-1074.
36. Haan, M.N., Shemanski, L., Jagust, W.J., Manolio, T.A., and Kuller, L. (1999). The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. Journal of the American Medical Association, 282 , 40-46.
37. Harris, T.B., Ferrucci, L., Tracy, R.P., Corti, M.C., Wacholder, S., Ettinger, W.H., Jr., Heimovitz, H., Cohen, H.J., and Wallace, R. (1999). Associations of elevated interleukin-6 and Creactive protein levels with mortality in the elderly. American Journal of Medicine, 106, 506-512.
38. Herskind, A.M., McGue, M., Holm, N.V., Sorensen T.I., Harvald, B., and Vaupel, J.W. (1996). The heritability of human longevity: A population-based study of 2872 Danish twin pairs born 1870-1900. American Journal of Human Genetics, 97 (3), 319-323.
39. Hjelmborg, J.B., Iachine, I., Skytthe, A., Vaupel, J.W., McGue, M., Koskenvuo, M., Kaprio, J., Pedersen, N.L., and Christensen, K. (2006). Genetic influence on human lifespan and longevity. American Journal of Human Genetics, (119 )3, 312-321.
40. Hume, A.L. (2005). Safe and effective drug therapy in older adults. Medicine and Health Rhode Island, 88 , 15-17.
41. Humphries, S.E., Luong, L.A., Ogg, M.S., Hawe, E., and Miller, G.J. (2001). The interleukin-6- 174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. European Heart Journal, 22 , 2243-2252.
42. Ioannidis, J.P. (2003). Genetic associations: False or true? Trends in Molecular Medicine, 9(4), 135-138.
43. Jordan, B.D., Relkin, N.R., Ravdin, L.D., Jacobs, A.R., Bennett, A., and Gandy, S. (1997). Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. Journal of the American Medical Association, 278 , 136-140.
44. Keavney, B., McKenzie, C., Parish, S., Palmer, A., Clark, S., Youngman, L., Delepine, M., Lathrop, M., Peto, R., and Collins, R. (2000). Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. (International Studies of Infarct Survival (ISIS) Collaborators.) Lancet, 355 , 434-442.
45. Kondo, S., Schutte, B.C., Richardson, R.J., Bjork, B.C., Knight, A.S., Watanabe, Y., Howard, E., de Lima, R.L., Daack-Hirsch, S., Sander, A., McDonald-McGinn, D.M., Zackai, E.H., Lammer, E.J., Aylsworth, A.S., Ardinger, H.H., Lidral, A.C., Pober, B.R., Moreno, L., Arcos-Burgos, M., Valencia, C., Houdayer, C., Bahuau, M., Moretti-Ferreira, D., Richieri-Costa, A., Dixon, M.J., and Murray, J.C. (2002). Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nature Genetics, 32 , 285-289.
46. Kritchevsky, S.B., Nicklas, B.J., Visser, M., Simonsick, E.M., Newman, A.B., Harris, T.B., Lange, E.M., Penninx, B.W., Goodpaster, B.H., Satterfield, S., Colbert, L.H., Rubin, S.M., and Pahor, M. (2005). Angiotensin-converting enzyme insertion/deletion genotype, exercise, and physical decline. Journal of the American Medical Association, 294 , 691-698.
47. Lewis, S.J., and Brunner, E.J. (2004). Methodological problems in genetic association studies of longevity: The apolipoprotein E gene as an example. International Journal of Epidemiology, 33 , 962-970.
48. Licastro, F., Pedrini, S., Caputo, L., Annoni, G., Davis, L.J., Ferri, C., Casadei, V., and Grimaldi, L.M. (2000). Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: Peripheral inflammation or signals from the brain? Journal of Neuroimmunology, 103, 97-102.
49. Lorenz, D., Frederiksen, H., Moises, H., Kopper, F., Deuschl, G., and Christensen, K. (2004). High concordance for essential tremor in monozygotic twins of old age. Neurology, 62 (2), 208-211.
50. Luft, F.C. (1999). Bad genes, good people, association, linkage, longevity, and the prevention of cardiovascular disease. Clinical and Experimental Pharmacology and Physiology, 26 , 576-579.
51. Mackness, B., Mackness, M.I., Arrol, S., Turkie, W., and Durrington, P.N. (1998). Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high-density lipoprotein against low-density lipoprotein oxidative modification. FEBS Letters, 423 (1), 57-60.
52. Martin-Ruiz, C.M., Gussekloo, J., van Heemst, D., von Zglinicki, T., and Westendorp, R.G. (2005). Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: A population-based study. Aging Cell, 4, 287-290.
53. McGue, M., and Christensen, K. (2001). The heritability of cognitive functioning in very old adults: Evidence from Danish twins aged 75 and older. Psychology and Aging, 16 , 272-280.
54. McGue, M., and Christensen, K. (2002). The heritability of level and rate-of-change in cognitive functioning in Danish twins aged 70 years and older. Experimental Aging Research, 28 (4), 435-451.
55. Montgomery, H.E., Marshall, R., Hemingway, H., Myerson, S., Clarkson, P., Dollery, C., Hayward, M., Holliman, D.E., Jubb, M., World, M., Thomas, E.L., Brynes, A.E., Saeed, N., Barnard, M., Bell, J.D., Prasad, K., Rayson, M., Talmud, P.J., and Humphries, S.E. (1998). Human gene for physical performance. Nature, 393 , 221-222.
56. Myerson, S., Hemingway, H., Budget, R., Martin, J., Humphries, S., and Montgomery, H. (1999). Human angiotensin I-converting enzyme gene and endurance performance. Journal of Applied Physiology, 87 , 1313-1316.
57. Nauck, M., Winkelmann, B.R., Hoffmann, M.M., Bohm, B.O., Wieland, H., and Marz, W. (2002). The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: No association with plasma interleukin-6, coronary artery disease, and myocardial infarction. International Journal of Molecular Medicine, 80, 507-513.
58. Nebel, A., Croucher, P.J., Stiegeler, R., Nikolaus, S., Krawczak, M., and Schreiber, S. (2005). No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans. Proceedings of the National Academy of Sciences, USA, 102, 7906-7909.
59. Panza, F., D'Introno, A., Colacicco, A.M., Capurso, C., Capurso, S., Kehoe, P.G., Capurso, A., and Solfrizzi, V. (2004). Vascular genetic factors and human longevity. Mechanisms of Ageing and Development, 125 , 169-178.
60. Petersen, A.M., and Pedersen, B.K. (2005). The anti-inflammatory effect of exercise. Journal of Applied Physiology, 98 , 1154-1162.
61. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., and Ridker, P.M. (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association, 286 , 327-334.
62. Puca, A.A., Daly, M.J., Brewster, S.J., Matise, T.C., Barrett, J., Shea-Drinkwater, M., Kang, S., Joyce, E., Nicoli, J., Benson, E., Kunkel, L.M., and Perls, T. (2001). A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proceedings of the National Academy of Sciences, USA, 98 , 10505-10508.
63. Rauramaa, R., Vaisanen, S.B., Luong, L.A., Schmidt-Trucksass, A., Penttila, I.M., Bouchard, C., Toyry, J., and Humphries, S.E. (2000). Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 2657-2662.
64. Ravaglia, G., Forti, P., Maioli, F., Chiappelli, M., Dolzani, P., Martelli, M., Bianchin, M., Mariani, E., Bolondi, L., and Licastro F. (2005). Associations of the-174 g/c interleukin-6 gene promoter polymorphism with serum interleukin 6 and mortality in the elderly. Biogerontology, 6(6), 415-423.
65. Reed, T., Dick, D.M., Uniacke, S.K., Foroud, T., and Nichols, W.C. (2004). Genome-wide scan for a healthy aging phenotype provides support for a locus near D4S1564 promoting healthy aging. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 59 , 227-232.
66. Rexbye, H., Petersen, I., Johansen, M., Klitkou, L., Jeune, B., and Christensen, K. (2006). Influence of environmental factors on facial ageing. Age and Ageing, 35 , 110-115.
67. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., and Soubrier, F. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation, 86 , 1343-1346.
68. Risch, N., and Zhang, H. (1995). Extreme sib pairs for mapping quantitative trait loci in humans. Science, 268 (5217), 1584-1589.
69. Robak, T., Gladalska, A., Stepien, H., and Robak, E. (1998). Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis. Mediators of Inflammation, 7, 347-353.
70. Ryff, C.D., and Singer, B.H. (2005). Social environments and the genetics of aging: Advancing knowledge of protective health mechanisms. Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 60(Spec No I), 12-23.
71. Seres, I., Paragh, G., Deschene, E., Fulop, T., Jr., and Khalil, A. (2004). Study of factors influencing the decreased HDL associated PON1 activity with aging. Experimental Gerontology, 39 (1), 59-66.
72. Silander, K., Komulainen, K., Ellonen, P., Jussila, M., Alanne, M., Levander, M., Tainola, P., Kuulasmaa, K., Salomaa, V., Perola, M., Peltonen, L., and Saarela, J. (2005). Evaluating whole genome amplification via multiply-primed rolling circle amplification for SNP genotyping of samples with low DNA yield. Twin Research and Human Genetics, 8(4), 368-375.
73. Skytthe, A., Pedersen, N.L., Kaprio, J., Stazi, M.A., Hjelmborg, J., Iachine, I., Vaupel, J.W., and Christensen, K. (2003). Longevity studies in GenomEUtwin. Twin Research and Human Genetics, 6(5), 448-454.
74. Swift, L.L., Zhu, M.Y., Kakkad, B., Jovanovska, A., Neely, M.D., Valyi-Nagy, K., Roberts, R.L., Ong, D.E., and Jerome, W.G. (2003). Subcellular localization of microsomal triglyceride transfer protein. Journal of Lipid Research, 44 , 1841-1849.
75. Tan, Q., Kruse, T.A., and Christensen, K. (2006). Design and analysis in genetic studies of human ageing and longevity. Ageing Research Reviews, (5)4, 371-387.
76. Terry, C.F., Loukaci, V., and Green, F.R. (2000). Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. Journal of Biological Chemistry, 275 , 18138-18144.
77. Wierzbicki, A.S. (2003). New lipid-lowering agents. Expert Opinion on Emerging Drugs, 8, 365-376.
78. Williams, A.G., Rayson, M.P., Jubb, M., World, M., Woods, D.R., Hayward, M., Martin, J., Humphries, S.E., and Montgomery, H.E. (2000). The ACE gene and muscle performance. Nature, 403, 614.
79. Winterer, G., Hariri, A.R., Goldman, D., and Weinberger, D.R. (2005). Neuroimaging and human genetics. International Review of Neurobiology, 67 , 325-383.
80. Yu, C.E., Oshima, J., Fu, Y.H., Wijsman, E.M., Hisama, F., Alisch, R., Matthews, S., Nakura, J., Miki, T., Ouais, S., Martin, G.M., Mulligan, J., and Schellenberg, G.D. (1996). Positional cloning of the Werner's syndrome gene. Science, 272 , 258-262.